Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP
Watch as Akhilesh Yadav addresses the crowd in Mainpuri, Uttar Pradesh, discussing key issues including unemployment, Covishield..
The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant and 61% against the Delta variant.
Watch as Akhilesh Yadav addresses the crowd in Mainpuri, Uttar Pradesh, discussing key issues including unemployment, Covishield..